$MYOV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Myovant Sciences Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Myovant Sciences Ltd.. Get notifications about new insider transactions in Myovant Sciences Ltd. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 04 2018 | MYOV | Myovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 20.27 | 1,110,015 | 22,500,004 | 38,341,357 | 37.2 M to 38.3 M (+2.98 %) |
| Apr 04 2018 | MYOV | Myovant Sciences L ... | QVT Associates GP LLC | Director | Buy | P | 20.27 | 1,110,015 | 22,500,004 | 38,341,357 | 37.2 M to 38.3 M (+2.98 %) |
| Mar 21 2018 | MYOV | Myovant Sciences L ... | Takeda Pharmaceuticals Interna ... | 10% Owner | Buy | P | 18.67 | 7,420,625 | 138,543,069 | 7,420,625 | 0 to 7.4 M |
| Mar 21 2018 | MYOV | Myovant Sciences L ... | Takeda Pharmaceuticals Interna ... | 10% Owner | Sell | S | 18.67 | 7,420,625 | 138,543,069 | 0 | 7.4 M to 0 (-100.00 %) |
| Oct 20 2017 | MYOV | Myovant Sciences L ... | Sebelius Kathleen | Director | Option Exercise | A | 13.14 | 22,500 | 295,650 | 22,500 | |
| Oct 20 2017 | MYOV | Myovant Sciences L ... | DeVeydt Wayne S | Director | Option Exercise | A | 13.14 | 22,500 | 295,650 | 22,500 | |
| Oct 20 2017 | MYOV | Myovant Sciences L ... | Curran Terrie | Director | Option Exercise | A | 13.14 | 22,500 | 295,650 | 22,500 | |
| Oct 20 2017 | MYOV | Myovant Sciences L ... | Altmeyer Mark | Director | Option Exercise | A | 13.14 | 22,500 | 295,650 | 22,500 | |
| Aug 17 2017 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | A | 10.60 | 260,000 | 2,756,000 | 260,000 | |
| Aug 17 2017 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Jul 18 2017 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | A | 11.30 | 310,000 | 3,503,000 | 310,000 | |
| Jun 02 2017 | MYOV | Myovant Sciences L ... | Seely Lynn | Principal Executive ... | Grant | A | 0.00 | 564,111 | 0 | 1,692,333 | 1.1 M to 1.7 M (+50.00 %) |
| May 17 2017 | MYOV | Myovant Sciences L ... | Altmeyer Mark | Director | Option Exercise | A | 12.68 | 11,154 | 141,433 | 11,154 | |
| May 17 2017 | MYOV | Myovant Sciences L ... | Sebelius Kathleen | Director | Option Exercise | A | 12.68 | 11,154 | 141,433 | 11,154 | |
| May 17 2017 | MYOV | Myovant Sciences L ... | DeVeydt Wayne S | Director | Option Exercise | A | 12.68 | 11,154 | 141,433 | 11,154 | |
| May 17 2017 | MYOV | Myovant Sciences L ... | Curran Terrie | Director | Option Exercise | A | 12.68 | 11,154 | 141,433 | 11,154 | |
| May 17 2017 | MYOV | Myovant Sciences L ... | Seely Lynn | Principal Executive ... | Option Exercise | A | 12.68 | 400,000 | 5,072,000 | 400,000 | |
| Apr 19 2017 | MYOV | Myovant Sciences L ... | Takeda Pharmaceuticals Interna ... | 10% Owner | Option Exercise | M | 0.00 | 4,432 | 0 | 0 | |
| Apr 19 2017 | MYOV | Myovant Sciences L ... | Takeda Pharmaceuticals Interna ... | 10% Owner | Buy | M | 0.00 | 4,432 | 0 | 7,420,625 | 7.4 M to 7.4 M (+0.06 %) |
| Mar 24 2017 | MYOV | Myovant Sciences L ... | Takeda Pharmaceuticals Interna ... | 10% Owner | Option Exercise | M | 0.00 | 13,091 | 0 | 0 | |
| Mar 24 2017 | MYOV | Myovant Sciences L ... | Takeda Pharmaceuticals Interna ... | 10% Owner | Option Exercise | M | 0.00 | 6,845 | 0 | 0 | |
| Mar 24 2017 | MYOV | Myovant Sciences L ... | Takeda Pharmaceuticals Interna ... | 10% Owner | Buy | M | 0.00 | 13,091 | 0 | 7,416,193 | 7.4 M to 7.4 M (+0.18 %) |
| Mar 24 2017 | MYOV | Myovant Sciences L ... | Takeda Pharmaceuticals Interna ... | 10% Owner | Buy | M | 0.00 | 6,845 | 0 | 7,403,102 | 7.4 M to 7.4 M (+0.09 %) |
| Mar 13 2017 | MYOV | Myovant Sciences L ... | Takeda Pharmaceuticals Interna ... | 10% Owner | Option Exercise | M | 0.00 | 5,727 | 0 | 0 | |
| Mar 13 2017 | MYOV | Myovant Sciences L ... | Takeda Pharmaceuticals Interna ... | 10% Owner | Option Exercise | M | 0.00 | 22,141 | 0 | 0 | |
| Mar 13 2017 | MYOV | Myovant Sciences L ... | Takeda Pharmaceuticals Interna ... | 10% Owner | Buy | M | 0.00 | 5,727 | 0 | 7,396,257 | 7.4 M to 7.4 M (+0.08 %) |
| Mar 13 2017 | MYOV | Myovant Sciences L ... | Takeda Pharmaceuticals Interna ... | 10% Owner | Buy | M | 0.00 | 22,141 | 0 | 7,390,530 | 7.4 M to 7.4 M (+0.30 %) |
| Nov 17 2016 | MYOV | Myovant Sciences L ... | Curran Terrie | Director | Option Exercise | A | 11.30 | 33,846 | 382,460 | 33,846 | |
| Nov 03 2016 | MYOV | Myovant Sciences L ... | Takeda Pharmaceuticals Interna ... | 10% Owner | Option Exercise | M | 0.00 | 1,977,269 | 0 | 0 | |
| Nov 03 2016 | MYOV | Myovant Sciences L ... | Takeda Pharmaceuticals Interna ... | 10% Owner | Buy | M | 0.00 | 1,977,269 | 0 | 7,368,389 | 5.4 M to 7.4 M (+36.68 %) |